Idelberto Raul Badell

7PUBLICATIONS
14CO-AUTHORS
Medical virologyRheumatology and arthritisRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 02, 2022
Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.

Wairimu Magua, Aileen C Johnson, Geeta M Karadkhele

|Nov 10, 2021
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States.

Geeta Karadkhele, Charlotte Duneton, Rouba Garro

|Feb 14, 2021
Every 2-month belatacept maintenance therapy in kidney transplant recipients greater than 1-year posttransplant: A randomized, noninferiority trial.

Idelberto R Badell, Ronald F Parsons, Geeta Karadkhele

|May 15, 2020
Superior inhibition of alloantibody responses with selective CD28 blockade is CTLA-4 dependent and T follicular helper cell specific.

Glenn Michael La Muraglia, Susan Zeng, Emma S Crichton

|Aug 28, 2019
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients.

Ronald F Parsons, Arslan Zahid, Shalini Bumb

|Jun 29, 2019
Circulating T follicular helper cells are a biomarker of humoral alloreactivity and predict donor-specific antibody formation after transplantation.

Glenn Michael La Muraglia, Maylene E Wagener, Mandy L Ford

Pageof 2

Frequent Collaborators

3 joint publications

Christian P Larsen

3 joint publications

Mandy L Ford

2 joint publications

Ronald F Parsons

2 joint publications

Glenn Michael La Muraglia